Autophagy inhibitors suppress environmental particulate matter-induced airway inflammation

Area of Science:

• Environmental Health
• Cell Biology
• Immunology

Background:

• Particulate matter (PM) exposure is a major cause of airway injury.
• Autophagy plays a key role in mediating PM-induced airway damage.
• Understanding protective mechanisms against PM exposure is crucial.

Purpose of the Study:

• To investigate the protective effects of autophagy inhibitors against PM-induced airway inflammation.
• To explore the role of spautin-1 and 3-Methyladenine (3-MA) in mitigating PM-related inflammatory responses.
• To elucidate the signaling pathway involved in autophagy inhibition-mediated protection.

Main Methods:

• Examined PM-induced autophagy in human bronchial epithelial (HBE) cells and mouse airways.
• Assessed the effects of spautin-1 and 3-MA on inflammatory cytokine expression in HBE cells.
• Evaluated neutrophil influx and proinflammatory cytokine levels in vivo after PM exposure and inhibitor treatment.
• Investigated the impact of autophagy inhibitors on the nuclear factor-kappa B (NF-κB) pathway.

Main Results:

• PM exposure triggered autophagy in HBE cells and mouse airways.
• Spautin-1 and 3-MA inhibited PM-induced inflammatory cytokine expression in HBE cells.
• In vivo, these inhibitors reduced neutrophil influx and proinflammatory cytokines caused by PM.
• Autophagy inhibitors suppressed inflammation by inhibiting the NF-κB pathway.

Conclusions:

• Autophagy inhibitors effectively decrease particulate matter-induced airway inflammation.
• Inhibition of the NF-κB pathway is the mechanism by which autophagy inhibitors exert their protective effects.
• Autophagy inhibitors represent a potential therapeutic strategy for preventing and treating PM-related airway injury.